The domestic market is small in Puerto Rico, per capita drug consumption is high and comparable to the US mainland which distinguishes it from other markets in the Americas. Local drug prices are significantly higher than on neighbouring islands and are more in line with US levels, having risen at an annual rate of around 3% in recent years.Strong growth in previous years has been linked to demographic and macroeconomic factors, with more innovative pharmaceuticals available in Puerto Rico than anywhere else in Latin America and the Caribbean. However, the island's poor economic prospects and the increasing number of plant closures have weakened its future growth outlook. Downward pressure due to economic recession and fiscal consolidation overall healthcare spending is expected to expand over the coming years.

Key View

SWOT

Industry Forecast

Industry Risk/Reward Index

Regulatory Development

Market Overview

Competitive Landscape

Company Profile

Puerto Rico Demographic Outlook 

Pharmaceuticals & Healthcare Glossary 

Pharmaceuticals & Healthcare Methodology